A monarch ails
—ARMANI SYED
DIAGNOSED
WHEN BUCKINGHAM PALACE ANNOUNCED on Feb. 5 that King Charles III had been diagnosed with an undisclosed type of can-n cer, it was a reminder—hardly needed so soon after Queen Elizabeth II’s death—that any monarchy rests on the backs of mortal beings.
The news led to an outpouring of solidarity as the 75-year-old began treatment at a London clinic. The King’s royal engagements have been postponed, with other members of the family, in their positions as his Counsellors of State, expected to stand in on his behalf; as the next in line to the throne, Prince William will likely play the most prominent role.
In announcing the King’s diagnosis but eliding details, the palace sought to “prevent speculation” while promoting public understanding, in line with the cancer-related charities he had long supported during his time as Prince of Wales. “In this capacity, His Majesty has often spoken publicly in support of cancer patients, their loved ones, and the wonderful health professionals who help care for them,” a Buckingham Palace spokesperson said, noting that the King is receiving “expert care” and looks forward to returning to his full duties.
The King’s health had been in public focus since he was admitted to a private clinic hospital in January for treatment of a benign prostate enlargement, during which a separate issue of concern was noted. At that moment too, the palace had made the King’s health news public in accordance with the monarch��
